These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7946424)

  • 1. [Movement disorders in Parkinson's disease: pathophysiology and therapeutic implications].
    Pascual-Leone A; Valls-Solé J; Hernández S; Hallett M
    Neurologia; 1994; 9(7):287-94. PubMed ID: 7946424
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effects of deep brain stimulation in Parkinson's disease.
    Freund HJ
    Brain; 2005 Oct; 128(Pt 10):2222-3. PubMed ID: 16183664
    [No Abstract]   [Full Text] [Related]  

  • 3. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and Parkinson's disease: a new look at an old problem.
    Edwards E; Kitt C; Oliver E; Finkelstein J; Wagster M; McDonald WM
    Depress Anxiety; 2002; 16(1):39-48. PubMed ID: 12203670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for neurodegenerative disorders: emerging clues from Parkinson's disease.
    Bjarkam CR; Sørensen JC
    Biol Psychiatry; 2004 Aug; 56(4):213-6. PubMed ID: 15312807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17th Symposium on the Treatment of Parkinson's Disease. September 27, 2008, Tokyo. Foreword.
    Kuzuhara S; Takahashi R
    J Neurol; 2009 Aug; 256 Suppl 3():269. PubMed ID: 19711115
    [No Abstract]   [Full Text] [Related]  

  • 8. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term stimulation of the ventral intermediate thalamic nucleus on gait in Parkinson's disease.
    Defebvre LJ; Blatt JL; Blond SC; Bourriez JL; Guieu JD; Destée A
    Adv Neurol; 1999; 80():627-30. PubMed ID: 10410781
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical treatment of movement disorders.
    Kluger BM; Klepitskaya O; Okun MS
    Neurol Clin; 2009 Aug; 27(3):633-77, v. PubMed ID: 19555825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation in Parkinson's disease.
    Dowsey-Limousin P; Fraix V; Benabid AL; Pollak P
    Funct Neurol; 2001; 16(1):67-71. PubMed ID: 11396273
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral subthalamic nucleus deep brain stimulation improves certain aspects of postural control in Parkinson's disease, whereas medication does not.
    Shivitz N; Koop MM; Fahimi J; Heit G; Bronte-Stewart HM
    Mov Disord; 2006 Aug; 21(8):1088-97. PubMed ID: 16671073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constraint-induced movement therapy in Parkinson's disease.
    Tuite P; Anderson N; Konczak J
    Mov Disord; 2005 Jul; 20(7):910-1. PubMed ID: 15929097
    [No Abstract]   [Full Text] [Related]  

  • 16. Pedunculopontine nucleus stimulation for people with Parkinson's disease? A clinical perspective.
    Gregory R
    Br J Neurosurg; 2008; 22 Suppl 1():S13-5. PubMed ID: 19085347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control and related disorders in Parkinson's disease: review.
    Lim SY; Evans AH; Miyasaki JM
    Ann N Y Acad Sci; 2008 Oct; 1142():85-107. PubMed ID: 18990123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the Parkinson's tremor and its treatments.
    Haeri M; Sarbaz Y; Gharibzadeh S
    J Theor Biol; 2005 Oct; 236(3):311-22. PubMed ID: 15950988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.